Statements (54)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:acquisition |
gptkb:Merck_Generics
gptkb:Roxane_Laboratories |
| gptkbp:awards |
Excellence in Manufacturing
Corporate_Social_Responsibility_Award Best_Pharmaceutical_Company |
| gptkbp:certifications |
gptkb:ISO_9001
GMP |
| gptkbp:communityEngagement |
Educational initiatives
Health awareness programs Sponsorship of health events |
| gptkbp:employees |
Over 1,000
|
| gptkbp:exportedTo |
Active pharmaceutical ingredients
Pharmaceutical products Healthcare_solutions |
| gptkbp:focus |
Manufacturing
Research and development Distribution |
| gptkbp:founded |
1978
|
| gptkbp:founder |
Samih Darwazah
|
| gptkbp:headquarters |
gptkb:Cairo
|
| https://www.w3.org/2000/01/rdf-schema#label |
Hikma Pharmaceuticals Egypt
|
| gptkbp:industry |
Pharmaceuticals
|
| gptkbp:investmentFocus |
Expansion of facilities
New product development Technology upgrades |
| gptkbp:market |
Middle_East_and_North_Africa
|
| gptkbp:parentCompany |
gptkb:Hikma_Pharmaceuticals_PLC
|
| gptkbp:partnerships |
Local universities
International research institutions Various healthcare organizations Healthcare_providers |
| gptkbp:products |
Topicals
Injectables Branded medications Liquid formulations Oral solids Generic_medications |
| gptkbp:regulatoryCompliance |
gptkb:FDA
EMA WHO |
| gptkbp:researchFocus |
Oncology
Cardiovascular diseases Infectious diseases Chronic diseases |
| gptkbp:revenue |
Over $1 billion
|
| gptkbp:serviceArea |
gptkb:Egypt
gptkb:North_Africa Middle_East |
| gptkbp:subsidiary |
gptkb:Hikma_Pharmaceuticals_PLC
|
| gptkbp:sustainabilityInitiatives |
Environmental management
Waste reduction programs Energy efficiency projects |
| gptkbp:website |
www.hikma.com
|